|
26 Companies |
|
51 Products |
|
51 Products |
|
56 Mechanisms of Action |
|
3 Trials |
|
839 News |
|
| «12345678910111213...1617» |
- Trial termination: Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity (clinicaltrials.gov) - Oct 3, 2015
P2, N=239, Terminated, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed --> Terminated; This study has been terminated. (Interim analysis of preliminary results indicated the need for protocol re-design).
- fezagepras (PBI-4050) / Liminal BioSci
New P2 trial: Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome (clinicaltrials.gov) - Sep 29, 2015
P2, N=36, Recruiting, Sponsor: ProMetic BioSciences Inc.
- |||||||||| New P3 trial: NWT03 and Arterial Stiffness (clinicaltrials.gov) - Sep 28, 2015
P3, N=80, Recruiting, Sponsor: Newtricious R&D BV
- Trial completion, Trial primary completion date: DIVAS2: Exercise-Induced Epigenetic Modifications in Obese Aging Women (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=21, Completed, Sponsor: University of Georgia
(Interim analysis of preliminary results indicated the need for protocol re-design). Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Dec 2014
- Trial completion, Enrollment change, Trial primary completion date: EPHIT: Effect of a High-Protein Diet and/or High-Intensity Training on Metabolic Syndrome (clinicaltrials.gov) - Sep 25, 2015
P=N/A, N=49, Completed, Sponsor: University of Georgia
Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Dec 2014 Active, not recruiting --> Completed | N=100 --> 49 | Trial primary completion date: Dec 2013 --> Mar 2013
- Trial primary completion date: The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome (clinicaltrials.gov) - Sep 24, 2015
P2, N=50, Recruiting, Sponsor: Florida State University
Active, not recruiting --> Completed | N=100 --> 49 | Trial primary completion date: Dec 2013 --> Mar 2013 Trial primary completion date: Aug 2015 --> Aug 2016
- Trial completion: Magnesium and Vascular Stiffness (clinicaltrials.gov) - Sep 16, 2015
P=N/A, N=52, Completed, Sponsor: Maastricht University Medical Center
Trial primary completion date: Aug 2015 --> Aug 2016 Recruiting --> Completed
- Trial completion, Adherence: MetSO: Promoting Adherence to Sleep Apnea Treatment Among Blacks With Metabolic Syndrome (clinicaltrials.gov) - Sep 14, 2015
P=N/A, N=344, Completed, Sponsor: New York University School of Medicine
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Enrollment change: Soy Nut Study on Markers of Health (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=18, Completed, Sponsor: University of California, Davis
Active, not recruiting --> Completed Recruiting --> Completed | N=36 --> 18
- Enrollment closed: HDL: Study of the Impact of Dairy Fat on Cardiovascular Health. (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=90, Active, not recruiting, Sponsor: Laval University
Recruiting --> Completed | N=36 --> 18 Recruiting --> Active, not recruiting
- New trial: Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome (clinicaltrials.gov) - Sep 4, 2015
P=N/A, N=20, Not yet recruiting, Sponsor: University of Connecticut
- New trial: Effects of TA-65, a Telomerase Activator on Metabolic Syndrome (clinicaltrials.gov) - Aug 24, 2015
P=N/A, N=40, Recruiting, Sponsor: University of Connecticut
- Enrollment change, Trial primary completion date: China Action on Spine and Hip Status (clinicaltrials.gov) - Aug 21, 2015
P=N/A, N=6000, Recruiting, Sponsor: Beijing Jishuitan Hospital
Recruiting --> Active, not recruiting N=3000 --> 6000 | Trial primary completion date: Dec 2015 --> Jun 2016
- triptorelin / Generic mfg.
Enrollment closed, Trial primary completion date: MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism (clinicaltrials.gov) - Aug 19, 2015
P4, N=20, Active, not recruiting, Sponsor: Herlev Hospital
N=3000 --> 6000 | Trial primary completion date: Dec 2015 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Oct 2015
- | Enrollment change, Trial termination, Trial primary completion date: Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT) (clinicaltrials.gov) - Aug 12, 2015
P2, N=61, Terminated, Sponsor: Virginia Commonwealth University
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Oct 2015 N=150 --> 61 | Recruiting --> Terminated | Trial primary completion date: Dec 2012 --> May 2012; Budgetary Issues
- ||| Biomarker, Trial completion, Trial primary completion date: EPIC-009: Metabolic Syndrome Feasibility Study (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=193, Completed, Sponsor: Epic Research & Diagnostics, Inc.
N=150 --> 61 | Recruiting --> Terminated | Trial primary completion date: Dec 2012 --> May 2012; Budgetary Issues Recruiting --> Completed | Trial primary completion date: Feb 2015 --> Jun 2015
- Biomarker, New trial: Identifying Biomarkers and Cardiovascular Risk Factors in Childhood Metabolic Syndrome (clinicaltrials.gov) - Aug 10, 2015
P=N/A, N=200, Recruiting, Sponsor: Chang Gung Memorial Hospital
- dobutamine / Generic mfg.
New trial: Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes (clinicaltrials.gov) - Jul 22, 2015
P=N/A, N=115, Recruiting, Sponsor: University of Avignon
- | Enrollment closed: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis (clinicaltrials.gov) - Jul 22, 2015
P3, N=60, Active, not recruiting, Sponsor: Bambino Ges
Recruiting --> Completed | Trial primary completion date: Feb 2015 --> Jun 2015 Recruiting --> Active, not recruiting
- | Xenical (orlistat) / Roche, GSK
New P1/2 trial: DRWMNTMS: Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome (clinicaltrials.gov) - Jul 21, 2015
P1/2, N=300, Completed, Sponsor: Republican Scientific Center for Emergency Medicine
- Somavert (pegvisomant) / Pfizer
Enrollment closed: Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes (clinicaltrials.gov) - Jul 17, 2015
P2, N=6, Active, not recruiting, Sponsor: University of California, San Francisco
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- || aripiprazole / Generic mfg.
Trial primary completion date: Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI (clinicaltrials.gov) - Jul 15, 2015
P=N/A, N=90, Recruiting, Sponsor: University of British Columbia
Recruiting --> Active, not recruiting Trial primary completion date: Apr 2015 --> Sep 2015
- New P2/3 trial: Effects of Flaxseed Supplementation in Metabolic Syndrome (clinicaltrials.gov) - Jul 14, 2015
P2/3, N=44, Completed, Sponsor: National Nutrition and Food Technology Institute
- New P1/2 trial: Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD (clinicaltrials.gov) - Jul 14, 2015
P1/2, N=21, Not yet recruiting, Sponsor: Lawson Health Research Institute
- New trial: Study of Chronic Degenerative Diseases (clinicaltrials.gov) - Jul 13, 2015
P=N/A, N=57, Recruiting, Sponsor: Asociaci
- |||| Enrollment open, Trial primary completion date: Effect of Implantable Contraception on Type-2 DM and Metabolic Syndrome in Women With History of Gestational DM (clinicaltrials.gov) - Jul 8, 2015
P2, N=260, Recruiting, Sponsor: Mahidol University
Trial primary completion date: Apr 2015 --> Sep 2015 Active, not recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Mar 2016
- Enrollment change, Trial withdrawal: Effect of Lycopene and Isoflavones on Glucose Metabolism (clinicaltrials.gov) - Jun 26, 2015
P=N/A, N=0, Withdrawn, Sponsor: The University of Texas Medical Branch, Galveston
Active, not recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Mar 2016 N=450 --> 0 | Suspended --> Withdrawn
- Trial primary completion date: Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome (clinicaltrials.gov) - Jun 25, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: Ohio State University
N=450 --> 0 | Suspended --> Withdrawn Trial primary completion date: Apr 2015 --> Jan 2015
- New trial: Maternal Hypertriglyceridaemia Study (clinicaltrials.gov) - Jun 24, 2015
P=N/A, N=400, Recruiting, Sponsor: University of Malaya
- Bydureon (exenatide XR once-weekly) / AstraZeneca
Trial completion: TAO: Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue (clinicaltrials.gov) - Jun 24, 2015
P3, N=45, Completed, Sponsor: Bjorn H. Ebdrup
Trial primary completion date: Apr 2015 --> Jan 2015 Recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: The Autonomic Nervous System and the Metabolic Syndrome (clinicaltrials.gov) - Jun 17, 2015
P=N/A, N=21, Completed, Sponsor: Vanderbilt University
Recruiting --> Completed Active, not recruiting --> Completed | N=50 --> 21 | Trial primary completion date: Dec 2015 --> May 2015
- Somavert (pegvisomant) / Pfizer
Trial primary completion date: Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes (clinicaltrials.gov) - Jun 11, 2015
P2, N=6, Recruiting, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed | N=50 --> 21 | Trial primary completion date: Dec 2015 --> May 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome (clinicaltrials.gov) - Jun 11, 2015
P1, N=13, Terminated, Sponsor: University of Connecticut
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Dec 2014 --> Jun 2014
- Trial primary completion date: Lifestyle Intervention for Polycystic Ovary Syndrome: Pulse-Based Diet and Exercise (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=166, Recruiting, Sponsor: University of Saskatchewan
Trial primary completion date: Dec 2014 --> Jun 2014 Trial primary completion date: Dec 2013 --> Apr 2016
- Trial primary completion date: Glycemic Index - Variability Among Individuals (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=124, Recruiting, Sponsor: Tufts University
Trial primary completion date: Dec 2013 --> Apr 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- || omega-3 ethylester concentrate / Generic mfg.
Trial primary completion date: Effects of Fish Oils on Inflammation and Insulin Resistance (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=135, Active, not recruiting, Sponsor: Philip Kern
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Dec 2014 --> Dec 2017
- | Trial termination: Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause (clinicaltrials.gov) - Jun 11, 2015
P3, N=126, Terminated, Sponsor: University of Erlangen-N
Trial primary completion date: Dec 2014 --> Dec 2017 Completed --> Terminated
- Enrollment change: CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=74, Completed, Sponsor: Palo Alto Medical Foundation
Completed --> Terminated N=100 --> 74
- Biomarker, Enrollment closed: STAR: Soybean Oil Trial of cArdiovascular Risk (clinicaltrials.gov) - Jun 10, 2015
P=N/A, N=60, Active, not recruiting, Sponsor: USDA Beltsville Human Nutrition Research Center
N=100 --> 74 Recruiting --> Active, not recruiting
- Enrollment open: Beneficial Effects of Exercise and Healthy Diets on Muscle and Adipose Tissue (clinicaltrials.gov) - Jun 9, 2015
P=N/A, N=115, Recruiting, Sponsor: University of Chile
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Trial completion, IO biomarker: ButCoIns GUTS: - Gut Immunological Effects of Resistant Starch and Arabinoxylans in Subjects With Metabolic Syndrome (clinicaltrials.gov) - May 29, 2015
P=N/A, N=22, Completed, Sponsor: University of Aarhus
Not yet recruiting --> Recruiting Recruiting --> Completed
- New trial: Effect of Oral Cinnamon Intervention in Metabolic Syndrome (clinicaltrials.gov) - May 28, 2015
P=N/A, N=103, Completed, Sponsor: Diabetes Foundation, India
- New trial: Effectiveness of Four Popular Diet Strategies for Weight Loss and Cardiac Risk Reduction (clinicaltrials.gov) - May 27, 2015
P=N/A, N=160, Completed, Sponsor: Tufts Medical Center
- Enrollment closed, Trial primary completion date, Surgery, Bariatric surgery: ADIII: Effect of Bariatric Surgery "Digestive Adaptations III" on Cardiovascular Risk (clinicaltrials.gov) - May 27, 2015
P2, N=30, Active, not recruiting, Sponsor: University of Sao Paulo
Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Sep 2015
- | Trial completion: Over-night Effect of Dietary Fiber on Glucose Metabolism and Satiety (clinicaltrials.gov) - May 27, 2015
P0, N=21, Completed, Sponsor: Lund University
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Sep 2015 Active, not recruiting --> Completed
- Trial completion: Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome (clinicaltrials.gov) - May 27, 2015
P=N/A, N=1, Completed, Sponsor: John Sievenpiper
Active, not recruiting --> Completed Active, not recruiting --> Completed
- galantamine extended release / Generic mfg.
Enrollment closed: GALANTA-MS: Galantamine Effects in Patients With Metabolic Syndrome (clinicaltrials.gov) - May 21, 2015
P4, N=60, Active, not recruiting, Sponsor: University of Sao Paulo
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change, Trial termination: Metabolic Syndrome in Bone Marrow Transplant Survivors (clinicaltrials.gov) - May 19, 2015
P=N/A, N=5, Terminated, Sponsor: Nationwide Children's Hospital
Recruiting --> Active, not recruiting N=15 --> 5 | Enrolling by invitation --> Terminated; Principal Investigator left the institution
- ||| New trial: The Impact of Metabolic Syndrome on Patients Undergoing Elective Laparotomy (clinicaltrials.gov) - May 19, 2015
P=N/A, N=105, Completed, Sponsor: University of Ioannina
- | Trial completion, Trial primary completion date: Study to Evaluate Safety and Efficacy of PreCrea (clinicaltrials.gov) - May 19, 2015
P3, N=210, Completed, Sponsor: Joe Fenn
N=15 --> 5 | Enrolling by invitation --> Terminated; Principal Investigator left the institution Recruiting --> Completed | Trial primary completion date: Jul 2014 --> Nov 2014